APA

Shimony S., Horowitz N., Ribakovsky E., Rozovski U., Avigdor A., Zloto K., Berger T., Avivi I., Perry C., Abadi U., Raanani P., Gafter-Gvili A. & Gurion R. (20200113). Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study. : Hematological oncology.

Chicago

Shimony Shai, Horowitz Netanel, Ribakovsky Elena, Rozovski Uri, Avigdor Abraham, Zloto Keren, Berger Tamar, Avivi Irit, Perry Chava, Abadi Uri, Raanani Pia, Gafter-Gvili Anat and Gurion Ronit. 20200113. Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study. : Hematological oncology.

Harvard

Shimony S., Horowitz N., Ribakovsky E., Rozovski U., Avigdor A., Zloto K., Berger T., Avivi I., Perry C., Abadi U., Raanani P., Gafter-Gvili A. and Gurion R. (20200113). Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study. : Hematological oncology.

MLA

Shimony Shai, Horowitz Netanel, Ribakovsky Elena, Rozovski Uri, Avigdor Abraham, Zloto Keren, Berger Tamar, Avivi Irit, Perry Chava, Abadi Uri, Raanani Pia, Gafter-Gvili Anat and Gurion Ronit. Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study. : Hematological oncology. 20200113.